AGP Executive Report
Last update: 7 hours agoDutch Biotech: Naarden-based NewAmsterdam Pharma says the EU has approved obicetrapib, its cholesterol treatment, for the first time worldwide. The company has also started a mid-stage trial testing the drug in preclinical Alzheimer’s disease. Blood Supply Security: A cyberattack targeted refrigeration systems at three French blood-service sites, raising temperatures in plasma stores. Staff detected the changes in time; no products were lost, and French authorities are investigating. Product Safety: The Dutch inspectorate has warned consumers about certain condoms following an EU-wide recall. Medical Devices: Philips has reached an agreement in principle with US regulators over its sleep-apnoea device recall, booking a €288 million provision. Financial Wellbeing: Queen Máxima is in Ghana to discuss financial health. While 81% of adults have a financial account, a 2021 study found only 22% were financially healthy.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
